目的 探讨自体动静脉内瘘的动脉-瘘管直径比对行经皮腔内血管成形术(percutaneous transluminal angioplasty,PTA)的患者手术后1年血管通路通畅性的影响。 方法 符合研究要求的维持性血液透析患者70例作为研究对象,对患者进行12个月的随访。当患者因再次失功需再次行PTA手术或进行内瘘再造时结束随访,将初级通畅时间<12个月分为A组(n=24),初级通畅时间≥12个月为B组(n=46),观察透析通路PTA后的初级通畅性。收集2组患者的基本临床资料,并进行统计学分析。 结果 A组患者年龄(t=8.237,P<0.001)、内瘘动脉-瘘管直径比(t=4.251,P<0.001)高于B组。Logistic回归分析显示:较高的内瘘动脉-静脉直径比是PTA手术后1年内再狭窄的独立预测因素(OR=0.000,95% CI:0.000~0.033,P=0.002)。ROC曲线分析显示内瘘动脉-静脉直径比曲线下面积(AUC)为0.788(95% CI:0.667~0.909,P<0.001),具有预测价值,其内瘘动脉-静脉直径比临界值为0.752。约登指数为0.576,敏感度为75.0%,特异度为82.6%。 结论 动脉-瘘管直径比高的PTA治疗患者手术后1年内存在较高的再次内瘘失功风险。
Objective To investigate the effect of artery-to-fistula diameter ratio of the arteriovenous fistula (AVF) on vascular access patency in patients after percutaneous transluminal angioplasty (PTA) for one year. Methods A total of 70 patients with maintenance hemodialysis and met the requirements of the study were selected as the study subjects. They were followed up for 12 months. When the patients needed to treat with PTA or AVF reconstruction due to re-occlusion, follow-up was terminated. According to the primary patency time, they were divided into two groups: group A (n=24, primary patency time <12 months) and group B (n=46, primary patency time ≥12 months) to observe their primary patency after PTA. Clinical characteristics of the two groups were collected and compared. Results The average age of group A was 72.33 years (range 65.22~79.44), significantly higher than that of group B (58.00 years, range 51.19~64.81). However, the artery-to-fistula diameter ratio of AVF were significantly higher in group A than in group B (t=4.251, P<0.001). Logistic regression showed that a higher artery-to-fistula diameter ratio of AVF was an independent predictor of restenosis within one year after PTA (OR=0.000, 95% CI: 0.000~0.033, P=0.002). ROC curve analysis showed that the area under the curve (AUC) of the artery-to-fistula diameter ratio of the AVF was 0.788 (95% CI: 0.667~0.909, P<0.05), and the cut-off value of the artery-to-fistula diameter ratio of the AVF was 0.752. The Youden index was 0.576, the sensitivity was 75.0%, and the specificity was 82.6%. Conclusion Patients with a higher artery-to-fistula diameter ratio of the AVF after PTA have a higher risk of re-fistula failure within one year.
[1] 金其庄, 王玉柱, 叶朝阳, et al. 中国血液透析用血管通路专家共识(第2版) [J]. 中国血液净化, 2019, 18(06): 365-81.
[2] 魏岁姣, 焦晶, 柏明, et al. 使用动静脉内瘘行维持性血液透析患者接受连续肾脏替代治疗时血管通路选择的研究进展 [J]. 临床肾脏病杂志, 2023, 23(09): 760-3.
[3] PIETRYGA J A, LITTLE M D, ROBBIN M L. Sonography of Arteriovenous Fistulas and Grafts [J]. Seminars in dialysis, 2017, 30(4): 309-18.
[4] Clinical practice guidelines for vascular access [J]. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, 48 Suppl 1: S248-73.
[5] KUKITA K, OHIRA S, AMANO I, et al. 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis [J]. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2015, 19 Suppl 1: 1-39.
[6] ROMANN A, BEAULIEU M C, RHéAUME P, et al. Risk factors associated with arteriovenous fistula failure after first radiologic intervention [J]. The journal of vascular access, 2016, 17(2): 167-74.
[7] 李志勇, 孔玉科, 周栋, et al. 经静脉途径球囊扩张治疗桡动静脉瘘狭窄 [J]. 中国医药指南, 2015, 13(03): 34-5.
[8] YANG C, GAO B, ZHAO X, et al. Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report [J]. Kidney international, 2020, 98(6): 1419-23.
[9] LEE J Y, KIM Y O. Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients [J]. The Korean journal of internal medicine, 2017, 32(5): 790-7.
[10] 肖祥, 马荣, 奉娅, et al. 不同血管通路血液透析患者的预后分析 [J]. 西部医学, 2020, 32(10): 1504-8.
[11] 王葳, 姜燕, 王巍巍, et al. 血液透析患者动静脉内瘘狭窄的机制研究与防治进展 [J]. 中国血液净化, 2012, 11(10): 564-7.
[12] 王博, 魏芳, 孙桂江, et al. 维持性血液透析患者自体动静脉内瘘使用时间及其影响因素研究 [J]. 中国全科医学, 2018, 21(29): 3577-81.
[13] 刘远浩, 郝国军, 唐斌. 超声引导下经皮腔内血管成形术与内瘘切除重建术治疗血液透析通路狭窄的临床研究 [J]. 中国中西医结合肾病杂志, 2020, 21(08): 723-4+54.
[14] 胡婷婷, 刘莉华, 马胜银, et al. DSA和彩超引导下的经皮血管成形术治疗血液透析患者动静脉内瘘狭窄的疗效 [J]. 安徽医学, 2020, 41(09): 1009-12.
[15] RANA A, WESTEIN E, NIEGO B, et al. Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities [J]. Frontiers in cardiovascular medicine, 2019, 6: 141.
[16] 迟雁青, 李闫, 郭藏卉, et al. PTA球囊扩张压力对动静脉内瘘狭窄PTA术后通畅率的影响及其危险因素分析 [J]. 解放军医学杂志, 2021, 46(11): 1085-91.
[17] 靖永胜, 王小平, 刘芳, et al. 动静脉内瘘功能障碍病理及发病机制的研究进展 [J]. 中华肾脏病杂志, 2017, (04): 318-20.
[18] YIN W, SHANMUGAVELAYUDAM S K, RUBENSTEIN D A. The effect of physiologically relevant dynamic shear stress on platelet and endothelial cell activation [J]. Thrombosis research, 2011, 127(3): 235-41.
[19] REZAPOUR M, TARAN S, BALIN PARAST M, et al. The impact of vascular diameter ratio on hemodialysis maturation time: Evidence from data mining approaches and thermodynamics law [J]. Medical journal of the Islamic Republic of Iran, 2016, 30: 359.
[20] KIM M J, KO H, HAN S, et al. Artery-to-Fistula Diameter Ratio as a Predictor of Early Re-Occlusion of Immature Right Radio-Cephalic Arteriovenous Fistula after Primary PTA [J]. Diagnostics (Basel, Switzerland), 2022, 12(9).
[21] KIM H K, HAN A, AHN S, et al. Better Efficacy of Balloon Assisted Maturation in Radial-Cephalic Arteriovenous Fistula for Hemodialysis [J]. Vascular specialist international, 2021, 37(1): 29-36.